PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 28(6): 637-640
2008
© 2008 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Furkert, J.
Right arrow Articles by Schwenger, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furkert, J.
Right arrow Articles by Schwenger, V.

Clinical

EFFECTS OF PERITONEAL DIALYSIS SOLUTIONS LOW IN GDPs ON PERITONITIS AND EXIT-SITE INFECTION RATES

Jürgen Furkert1, Martin Zeier2 and Vedat Schwenger2

Nephrology and Gastroenterology,1 SLK-Kliniken Heilbronn, Bad Friedrichshall; Department of Nephrology,2 University Hospital Heidelberg, Heidelberg, Germany

Correspondence to: J.D. Furkert, Nephrology and Gastroenterology, SLK-Kliniken Heilbronn, Am Plattenwald 1, Bad Friedrichshall, 74177, Germany. juergen.furkert{at}slk-kliniken.de

{diamondsuit} Background: Peritoneal dialysis (PD) solutions sterilized at a low pH level contain only minimal amounts of glucose degradation products (GDPs). The latter are known to have an adverse effect on the peritoneal membrane. The present study retrospectively analyzes the effects on the incidences of peritonitis and exit-site infections.

{diamondsuit} Materials and Methods: Data concerning the frequency of peritonitis and exit-site infections for 120 patients treated with PD were collected. Before 2000, 67 of these patients received conventional dialysates and from 2000 on, 53 patients were treated with the new dialysis fluids. Furthermore, a correlation between the incidence of infections and the duration of treatment with dialysis was established.

{diamondsuit} Results: It was observed that the use of dialysis solutions low in GDPs resulted in significantly lower rates of peritonitis (p = 0.002) and exit-site infections (p = 0.02). When using the new treatment, peritonitis occurred, on average, after 48 months of treatment and exit-site infections after 34 months of treatment.

{diamondsuit} Discussion: The result supports the hypothesis that the use of the new, biocompatible, PD solutions contributes to considerable reduction in the rates of peritonitis and exit-site infections. As it is not expected that randomized prospective studies will be conducted in the future, further observational studies should be carried out in order to affirm the observed tendencies.

KEY WORDS: Peritonitis; exit-site infections; dialysis solutions.

Received 11 December 2007; accepted 25 May 2008.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2008 by Multimed Inc.